Sunday, May 26, 2019

Granules India gains 2% on USFDA approval for Methylphenidate Hydrochloride capsules

Methylphenidate Hydrochloride extended-release capsules are used for the treatment of attention deficit hyperactivity disorder (ADHD).

from Moneycontrol http://bit.ly/2EAGW6w
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Trading Books